ǂa ǂposition paper
Martin Rakuša (Avtor), Serefnur Öztürk (Avtor), Elena Moro (Avtor), Raimund Helbok (Avtor), Claudio Bassetti (Avtor), Ettore Beghi (Avtor), Daniel Bereczki (Avtor), Benedetta Bodini (Avtor), Giovanni Di Liberto (Avtor), Tom Jenkins (Avtor)

Povzetek

Background and purpose Health risks associated with SARS-CoV-2 infection are undisputed. Moreover, the capability of vaccination to prevent symptomatic, severe, and fatal COVID-19 is recognized. There is also early evidence that vaccination can reduce the chance for long COVID-19. Nonetheless, the willingness to get vaccinated and receive booster shots remains subpar among people with neurologic disorders. Vaccine scepticism not only jeopardizes collective efforts to end the COVID-19 pandemic but puts individual lives at risk, as some chronic neurologic diseases are associated with a higher risk for an unfavorable COVID-19 course. Methods In this position paper, the NeuroCOVID-19 Task Force of the European Academy of Neurology (EAN) summarizes the current knowledge on the prognosis of COVID-19 among patients with neurologic disease, elucidates potential barriers to vaccination coverage, and formulates strategies to overcome vaccination hesitancy. A survey among the Task Force members on the phenomenon of vaccination hesitancy among people with neurologic disease supports the lines of argumentation. Results The study revealed that people with multiple sclerosis and other nervous system autoimmune disorders are most skeptical of SARS-CoV-2 vaccination. The prevailing concerns included the chance of worsening the pre-existing neurological condition, vaccination-related adverse events, and drug interaction. Conclusions The EAN NeuroCOVID-19 Task Force reinforces the key role of neurologists as advocates of COVID-19 vaccination. Neurologists need to argue in the interest of their patients about the overwhelming individual and global benefits of COVID-19 vaccination. Moreover, they need to keep on eye on this vulnerable patient group, its concerns, and the emergence of potential safety signals.

Ključne besede

advocacy;infectious disease prevention;neurological disorders;vaccine skepticism;

Podatki

Jezik: Angleški jezik
Leto izida:
Tipologija: 1.01 - Izvirni znanstveni članek
Organizacija: UM - Univerza v Mariboru
Založnik: Blackwell Science
UDK: 616.8
COBISS: 108168963 Povezava se bo odprla v novem oknu
ISSN: 1468-1331
Št. ogledov: 25
Št. prenosov: 0
Ocena: 0 (0 glasov)
Metapodatki: JSON JSON-RDF JSON-LD TURTLE N-TRIPLES XML RDFA MICRODATA DC-XML DC-RDF RDF

Ostali podatki

Sekundarni jezik: Slovenski jezik
Sekundarne ključne besede: COVID-19;Communicable diseases;Nervous system diseases;SARS-CoV-2;Vaccination;
Vrsta dela (COBISS): Znanstveno delo
Strani: str. 2163-2172
Letnik: ǂVol. ǂ29
Zvezek: ǂissue ǂ8
Čas izdaje: Aug. 2022
DOI: 10.1111/ene.15368
ID: 24399291